Preview

Healthcare

Advanced search

Risk factors for the development and progression of retinopathy of prematurity and the optimization of its screening

https://doi.org/10.65249/1027-7218-2025-11-24-31

Abstract

Objective. To study risk factors for the development and progression of retinopathy of prematurity (ROP) and to develop practical recommendations for the timely detection of severe forms of the disease.

Material and methods. A data analysis of 7022 preterm infants (gestational age less than 33 weeks, birth weight less than 2000 g) was performed, including univariate and multivariate assessment of the influence of perinatal factors. Based on the obtained data, a risk scoring scale (Neo-ROP-8) adapted for clinical use was created.

Results. It was established that key risk factors are sepsis (OR = 22.5), prolonged oxygen therapy (more than 28 days, OR = 12.3), intraventricular hemorrhage (OR = 6.9), and blood transfusion (OR = 5.7). Gestational age and birth weight have a protective effect: each additional week of gestation reduces the risk of ROP by 28 %, and each 100 g increase in birth weight reduces it by 15 %. The Neo-ROP-8 scale with a threshold of 7 points or more allows for the detection of 85 % of ROP cases with 90 % accuracy. Infants with severe retinal immaturity (vessels in zone 1) have a 97.5 % risk of progression to terminal stages.

Conclusion. Risk factors for the development and progression of ROP coincide. The use of the Neo-ROP-8 scale in combination with the assessment of retinal maturity allows for the optimization of screening timing without loss of diagnostic quality. 

About the Authors

V. Krasilnikova
Институт повышения квалификации и переподготовки кадров здравоохранения УО «Белорусский государственный медицинский университет»
Belarus


O. Dudich
Институт повышения квалификации и переподготовки кадров здравоохранения УО «Белорусский государственный медицинский университет»
Belarus


I. Smirnov
10-я городская клиническая больница
Belarus


References

1. Screening Examination of Premature Infants for Retinopathy of Prematurity / W. M. Fierson ; American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus // Pediatrics. — 2018. — Vol. 142, № 6. — doi: 10.1542/peds.2018-3061.

2. International Classification of Retinopathy of Prematurity, Third Edition (ICROP3) / M. F. Chiang, G. E. Quinn, A. R. Fielder [et al.] // Ophthalmology. — 2021. — Vol. 128, № 10. — doi: 10.1016/j.ophtha.2021.05.031.

3. Revised indications for the treatment of retinopathy of prematurity : results of the early treatment for retinopathy of prematurity randomized trial / Early Treatment for Retinopathy of Prematurity Cooperative Group // Archives of Ophthalmology. — 2003. — Vol. 121, № 12. — doi: 10.1001/archopht.121.12.1684.

4. Final visual acuity results in the early treatment for retinopathy of prematurity study / Early Treatment for Retinopathy of Prematurity Cooperative Group ; W. V. Good, R. J. Hardy, V. Dobson [et al.] // Archives of Ophthalmology. — 2010. — Vol. 128, № 6. — P. 663—671.

5. Effect of red blood cell transfusion on the development of retinopathy of prematurity : a systematic review and meta-analysis / Z. Zhu, X. Hua, Y. Yu [et al.] // PLoS One. — 2020. — Vol. 15, № 6. — doi: 10.1371/journal.pone.0234266.

6. Neonatal sepsis episodes and retinopathy of prematurity in very preterm infants / K. Glaser, C. Hartel, C. Klingenberg [et al.] // JAMA Network Open. — 2024. — Vol. 7, № 7. — doi: 10.1001/jamanetworkopen.2024.23933.

7. The use of postnatal weight gain algorithms to predict severe or type 1 retinopathy of prematurity : a systematic review and meta-analysis / S. Athikarisamy, S. Desai, S. Patole [et al.] // JAMA Network Open. — 2021. — Vol. 4, № 11. — doi: 10.1001/jamanetworkopen.2021.35879.

8. Factors in premature infants associated with low risk of severe retinopathy of prematurity / K. C. Wade, Gui-Shuang Ying, A. Baumritter [et al.] // JAMA Ophthalmology. — 2019. — Vol. 137, № 3. — P. 262—270.


Review

For citations:


Krasilnikova V., Dudich O., Smirnov I. Risk factors for the development and progression of retinopathy of prematurity and the optimization of its screening. Healthcare. 2025;1(11):24-31. (In Russ.) https://doi.org/10.65249/1027-7218-2025-11-24-31

Views: 10


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1027-7218 (Print)